Dr. Reddy's Laboratories, Inc. has recalled 16,449 bottles of Progesterone Capsules (200 mg) because the medication failed dissolution testing during quality stability checks. This means the drug may not dissolve properly in the body, which can prevent the patient from receiving the correct amount of active medication. These prescription capsules were sold in 100-count bottles and distributed nationwide across the United States. Consumers should check their prescription bottles immediately for the specific batch and expiration date listed below.
The failure of the drug to dissolve at the required rate can lead to decreased absorption of the medication into the bloodstream. This may result in ineffective treatment for the patient's underlying condition, as the body is not receiving the intended dose of progesterone.
Contact healthcare provider and return product to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.